CVM Archives - Page 3 of 3 - Blue Horseshoe Stocks

Blue Horseshoe: Pot Stocks Update & More

Pot Stocks Update
–
Even as we’ve had other things occupying our main focus, we’ve stated continuously that traders should keep the cannabis sector on close watch. Following the complete hysteria over the industry which reached its peak shortly after we rung in the new year, we’ve seen just what we expected; consolidations leading to bounces that in many cases have been good for gains approaching those achieved by the New Year’s rush. So let’s take a look at some of the more notable performers from our long-standing watchlist. These represent just a few of the opportunities that marijuana related stocks have continued to bring us. We are not done with this sector by any means, and feel strongly that it will yield more and more gains as time goes on.

ENDEXX Corp. EDXC

We’ve had EDXC on our radar for a very long time, and it is one that didn’t lose much ground at all after pulling back off of its initial surge. Beginning at less than seven cents, 2014 has seen the stock continue to bull its way upward, touching .235 yesterday. It’s certainly a far cry from when we first came upon the stock last year, back when it was trading at roughly .015.

Cannabis Science, Inc. CBIS

CBIS has made quite an impressive bounce after consolidating off of its big run, finding support at .075; from there, it launched itself back upward for a sizable move to yesterday’s high of .1255. That marks a three-session move of 67%

Creative Edge Nutrition, Inc. FITX

The last time we looked in on FITX was on January 14th, at which time the stock was searching for support, and found it at .0174 the following day. It didn’t take long for the stock to produce yet another huge run, touching .045 during yesterday’s session. It broke above an area of previous resistance at .031, so on the next downswing, we’ll be looking for FITX to hold that level as support.

We’ve already pointed out how powerful a signal the Golden Cross can be, and FITX is yet another prime example of this. That’s why we’ve been keeping such a keen eye on our next play, because it too has a Golden Cross in the making.

Resource Ventures, Inc. REVI

REVI held its ground very well yesterday, after our bounce-call on Tuesday took it from .0074-.0105. It registered a higher low at .0085, and managed to close out the day in the green at .009. We’d like to see REVI continue to hold support in the .0075-.0085 as it works toward its Golden Cross, which if the current trend holds, could potentially occur within the next week or two.

ARIAD Pharmaceuticals, Inc. ARIA & Hemishperix BioPharma, Inc. HEB

We’ve been tracking both of these pharma plays for awhile, which are worthy of mentioning this morning:

ARIA

We mentioned ARIA back in October when it was trading around its 52-week low at 2.15. In Mid-December, it began a run which yesterday resulted in a high of 6.75. This morning the stock is gapping up into the 7.30-range.

ARIA has been the subject of potential buyout rumors originating in the UK, with names like GlaxxoSmithKline being tossed around. While this remains speculation at this time, the ramifications of a buyout would be huge, so this is a story we’ll continue to follow.

HEB

In the case of HEB, we’ve tracked this play since December, where it found a bottom in the low .20’s, and has performed exceptionally well into the new year. Yesterday the stock hit a high of .4978.

Extended Watchlist:
PSTI, INO, CVM, CBMX

PROW, REVI & Extended Watchlist

Progress Watch Corp. PROW
–
We first introduced PROW to our reports on December 20th, when it was trading at a low of .0065. At that time, we pointed out the likelihood of a Golden Cross, and witnessed one just a couple weeks later. That signaled what would turn out to be an astonishingly impressive week-long breakout to a high of .0488, a rise of 650% from our initial alert price. Quite a move, considering it only took a little over three weeks to transpire.

PROW, is also extremely relevant to yesterday’s report on REVI, because it illustrates the potential power of the elusive Golden Cross chart formation.

Resource Ventures, Inc. REVI

We were pleased with the quick-strike opportunity our alert on REVI offered us yesterday. After opening at its low of day (.0074) the stock surged to a subsequent high of .0105, affording sharp traders the chance at gains of up to 42% After receding from that initial push, the stock found support at .008, bouncing back to .009 before closing at .0087, up 17.5% on the day and trading over 30% more volume than its 3mo. average.

We consider that an extremely solid performance from a stock being mentioned in our reports for the first time, and our call of the possible bounce from the .0074-level couldn’t have been timed any better.

We’re not done following this play, however, as it appears this company is doing everything in its power to improve its process and ensure its positioning for positive growth in the future. We’ll leave the recent press highlights we outlined in yesterday’s special report intact below for anyone who might have missed it; we’re looking forward to seeing how the company follows through with everything it currently has in the works. We also have the impending Golden Cross angle to follow, as we mentioned above; REVI is even closer to its potential Golden Cross than PROW was when we first mentioned it. So the potential for further gains in the days and weeks to come is certainly present. While past performances are no guarantee of future results, we’ve seen the Golden Cross scenario play out so many times to a positive effect, that we would be remiss not to point it out.

We’re also looking at a fresh news release the company put out this morning:

SILVERADO CA–(Marketwired – Jan 22, 2014) – Resource Ventures, Inc. (PINKSHEETS: REVI) President Bob Thompson announced today that the Company’s wholly owned subsidiary, Resources Printing and Graphics, Inc. (RP&G) has achieved a milestone in their Promotional Products, in that the division has grown to represent more than 25% of the company’s overall revenue.

“15 years ago RP&G started their Promotional Products division to satisfy the many customer requests received on a daily basis, RP&G’s printing customers kept pressing us to take on more of their other graphic needs; they like the 24/7 service we offer, and just wanted us to do more for them,” said Bob Thompson, President of Resource Ventures Inc. “Now over a half million products are offered from pens to cups to watches; anything you want to put logo or message on, we can likely do.”

RECENT PRESS HIGHLIGHTS:

– Company expects to report over $2M in revenue for year ending 12/31/13, a year-over-year rise in in excess of 40-50% (Report due no later than 04/01)

– Planned exchange uplisting, process for which could begin as early as Q2

– Company has committed to timely release of all pertinent data while it remains on OTC Pink

– New online store “WikiClickPrint.com” in “fast-track development” mode

www.resourcesprinting.com

Extended Watchlist:
BBRY, KOOL, EVOK, MSTX, DRWI, MELA, CVM

ATOS, CTIC, APP & Extended Watchlists

Atossa Genetics, Inc. ATOS

–
We tacked ATOS onto our extended watchlist yesterday morning, noting that the stock was in the midst of a “Huge gap down” and that we were “watching for a potential bounce”. Indeed that was the case, as the stock touched a low of 2.54 before a reversal carried it as high 3.18, a 25% intraday gain. As usual, when we see big gap-downs, we are looking out for quick-strike opportunities that allow us to make a rapid profit and a timely exit.We have uncovered a few other stocks fitting that profile that we will be monitoring for similar activity today:

Tower Group Intl. Ltd. TWGP

CEL-SCI Corp. CVM

Celgene Corp. CELGZ

Cell Therapeutics, Inc. CTIC
Another play from yesterday’s extended watchlist, CTIC opened at its low of day, and rumbled upward for a 23% move, closing at the high of day on nearly 12X its 3mo. average volume. In doing so, it managed to break a previous swing high at 1.80, a level we’d like to see hold as support moving forward.

We prepared the the following video chart on CTIC:

With the kind of momentum CTIC built up over the course of the day yesterday, this is one play that will be near the top of our watchlists in the near future. The catalyst here seems to be an agreement announced yesterday between the company and the FDA as outlined in the press release below.

SEATTLE, Oct. 7, 2013 /PRNewswire via COMTEX/ — Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today announced that the company reached agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) for the planned pivotal Phase 3 clinical trial, known as the PERSIST-2 trial, evaluating pacritinib compared to best available therapy, including approved JAK2 inhibitors such as ruxolitinib, in patients with myelofibrosis whose platelet counts are <100,000/uL. The SPA is a written agreement between CTI and the FDA regarding the design, endpoints and planned statistical analysis approach of the trial to be used in support of a potential New Drug Application (NDA) submission. The PERSIST-2 trial is the second of two planned Phase 3 clinical trials in patients with myelofibrosis. CTI expects to initiate the PERSIST-2 clinical trial in the fourth quarter of 2013. >>> FULL STORY

American Apparel, Inc. APP

APP is another stock we have tracked for an extended period of time. We have been watching this one to sniff out a bottom for the past few months, and wanted to re-enter it into the conversation today, as that point may be drawing near. A quick peek at the chart below clearly shows just that:

Extended Watchlist:

JCP, AGEN, CBMX, NAVB, TKMR

NVIV, CVM, IWEB & Extended Watchlist

InVivo Therapeutics Holdings Corp. NVIV
–
NVIV has traded as low as 4.84 since the first time we talked about it back on Monday, July 15th, and after just five trading days, hit a high of 6.20 this past Monday.

We’re going to have this stock on our longer-term watchlist moving forward, and would like to see the stock maintain support above 5.00. The technologies they have developed have the potential to be game-changers in the field of spinal cord injury treatment.

Earlier this month, InVivo announced it would be teaming up with the New York Mets to create Major League Baseball’s first Spinal Cord Injury Awareness Day on Sunday, September 15th at Citi Field when the New York Mets host the Miami Marlins at 1:10 p.m. ET.

More Info @

www.invivotherapeutics.com

CEL-SCI Corp. CVM

We want to add CVM to our radars this morning. The stock hit its 52-low of .16 just prior to the closing bell yesterday afternoon, and this morning the company had some fresh news hit the wires. We want to watch this one closely, as conditions like these can often lead to significant bottom bounces.

Today’s PR:

CEL-SCI Corporation (NYSE MKT: CVM) announces the publication of the results of influenza studies by researchers from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) and CEL-SCI in the Journal of Clinical Investigation, a leading journal for discoveries in basic and clinical biomedical research (2013 J Clin Invest. doi: 10.1172/JCI67550 2013, supplemental information at www.jci.org/articles/view/67550). The studies described in the publication show that when CEL-SCI’s investigational J-LEAPS Influenza Virus treatments were used “in vitro” to activate immune cells called dendritic cells (DCs), these activated dendritic cells, when injected into influenza infected mice, arrested the progression of lethal influenza virus infection in these mice. >>> FULL STORY

IceWEB, Inc. IWEB

Yesterday morning we stated our hope that IWEB would break through resistance at .0355- it did that and more. After touching an early morning low of .032, the stock went on a 22% intraday run, with shares trading at .039 at their peak.

In addition, the stock closed with strength (.036), above previous resistance at .0355, maintaining more than half of its daily gains on over 5X its 3mo. average volume, which is often a bullish signal.

From the low following our original alert of IWEB at .023, yesterday’s high represents an overall move of 70% Since that time, the cumulative gains attained by IWEB have amounted to more than 115% in possible profits.

BARCHART.COM has also upgraded its opinion of IWEB to a 72% Overall “Buy” Rating.

Extended Watchlist:
VPLM, DANG, RENN, XRX,